in

Need for vaccine aspiration confirmed, why is this not being done

Oxford vaccine and blood clots

https://www.dailymail.co.uk/news/article-10266585/AstraZeneca-uncovers-trigger-blood-clots-jab.html

https://www.gov.uk/government/publications/covid-19-vaccination-blood-clotting-information-for-healthcare-professionals/information-for-healthcare-professionals-on-blood-clotting-following-covid-19-vaccination

From 4 January to 4 August

AZ vaccine administered across the UK

24.8 million first doses

23.9 million second doses

412 suspected cases of CVST (Cerebral Sinus Vein Thrombosis) have been reported across the UK

(Only 43 suspected cases were after the second dose of AZ vaccine)

Overall incidence of CVST

After first dose, 14.9 per million

After second dose, 1.8 per million

CVST is a complication of COVID-19 infection

42.8 per million

MHRA as of 11 August, there were 73 fatal cases from the 411 events

ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome

https://www.science.org/doi/10.1126/sciadv.abl8213

Vaccines derived from chimpanzee adenovirus

As part of the largest vaccination campaign in history,

Ultra rare side effects not seen in phase 3 trials,

including thrombosis with thrombocytopenia syndrome (TTS)

Adenoviruses deployed as vaccination vectors versus SARS-CoV-2 bind to platelet factor 4 (PF4),

a protein implicated in the pathogenesis of HIT.

heparin-induced thrombocytopenia

Computational simulations to demonstrate an electrostatic interaction mechanism with PF4,

which was confirmed experimentally by surface plasmon resonance.

These data confirm that PF4 is capable of forming stable complexes with clinically relevant adenoviruses,

an important step in unravelling the mechanisms underlying TTS.

Platelet factor 4 (PF4)

https://en.wikipedia.org/wiki/Platelet_factor_4

https://www.nature.com/articles/s41420-019-0188-0

https://www.sciencedirect.com/topics/neuroscience/platelet-factor-4

This chemokine is released from activated platelets during platelet aggregation, and promotes blood coagulation

Also has a role in inflammation and wound repair

Prof Alan Parker, Cardiff University

The adenovirus has an extremely negative surface, and platelet factor four is extremely positive and the two things fit together quite well

What we have is the trigger, but there’s a lot of steps that have to happen next

Recent case reports show that most patients presenting with TTS

( more than 90%) tested positive for PF4 antibodies

A ChAdOx1/PF4 complex could induce anti-PF4 autoantibodies.

In this potential mechanism, small quantities of ChAdOx1 enter the blood through minor capillary injuries

caused by the intramuscular injection, as has previously been observed

This proposal goes some way toward explaining why TTS is observed so rarely,

because it may require a series of low frequency stochastic interactions,

first between small numbers of adenovirus particles entering the blood / lymph and then monocytes and / or B cells,

which may only occur in individuals who are predisposed toward the generation of anti-PF4 antibodies.

https://www.bbc.com/news/health-59418123

Written by Dr. John Campbell

Hello Everyone,My name is John Campbell and I am a retired Nurse Teacher and A and E nurse based in England. I also do some teaching in Asia and Africa when time permits. These videos are to help students to learn the background to all forms of health care. My PhD focused on the development of open learning resources for nurses nationally and internationally.

Comments

Leave a Reply
  1. In the USA at Jefferson Hospital they refused to aspirate… They said you dont know what you are talking about that they dont have to because no matter what it is supposed to get in the blood stream…. Plz respond to them i want to show them you are not fake news that you know more then they do

  2. My husband and I got our 2nd J&J on October 29th, we requested the nurse aspirate, she said absolutely!(I'm also a nurse) I watched her aspirate prior to injection for both of us. (We're in the PNW in the U.S..)

  3. John: As your interviewees have told you from around the world and as your viewrs no, those reported cases are LOW because doctors, nurses, hospitals are avoiding patients and testing testing sensing them home and avoiding appointments! This is NOT rare😒

  4. Se we are waiting for data? Isint data being suppressed? By media? They are telling fools that strokes and heart attacks in childrens are normal. You have a huge responsibility to help people be aware of this shit. Theres little time left. This is ramping up.

  5. The authorities will never concede that aspirating would be safer.
    That would acknowledge they are responsible for thousands of horrible injuries … It won’t happen.
    Instead they will double down causing even more injuries.
    And you can bet your life Prof’ Alan Parker knows how it’s happening … but he’s not allowed to say so.

  6. Because there is no liability for any wrongs, there is no need for the systems to make sure injections are done to the highest standard. This lack of professionalism is just a new lower standard acceptable in the medical systems. They don't care if there is some collateral damage to people. For the sake of speedy processing, standards have been lowered. The bigger picture of prevention of illness in the masses is a higher priority. One doesn't have to wonder how important life is to some and people shouldn't have to wonder why some refuse to play Russian roulette! It's like selling a new car without wheels and the miffed sales person wondering why the consumer gets upset about the lack of wheels!

  7. i just read this from a study done at cardiff university : The new study shows that adenovirus attracts a protein called “platelet factor four” to it like a magnet.

    This new hybrid protein-virus confuses the immune system, which creates new antibodies, which themselves stick to the proteins, triggering the formation of dangerous blood clots.

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0